Market Access and Evidence Generation Strategies

At every stage of your product’s lifecycle, we can help you develop a strategic roadmap to effectively demonstrate and communicate your product’s value. For clinical and commercial teams alike, we provide extensive research experience, industry and regulatory knowledge, and evidence-based tools to help commercialize your product. 

To determine your best commercialization strategy, we can help you develop and execute a plan that includes:

  1. Environmental Scans: Commercial, clinical, payer strategy, and health economics
  2. Literature Reviews: Disease, burden of illness, treatment pathway, epidemiology and unmet need
  3. A Gap Analysis
  4. Target Product Profile (TPP) Assessment
  5. A Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis
  6. Proven and Projected Value Assessments: Clinical, economic, PRO/QoL value
  7. A Roadmap: Tactical project and study recommendations for filling the gaps

Market Access Planning Across the Product Lifecycle

Although it is never too late to develop a market access strategy, for the best positioning of your product, you should begin in Phase 2 of clinical development. Tasks to support the strategy should include the following activities.

MA Planning

PR = Pricing Research; MA = Market Access; HTA = Health Technology Assessment